Award task order: "analytical method development and validation, characterization, and stability studies of ML-246" under contract: "CRO support for ncats drug substance development and manufacture"
Ended Awarded Last action
- Contract number
- HHSN27100001
- Awardee
-
Mriglobal UEI HKQHNFKNKL15
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $131,421
Award facts
- Opportunity
-
- N01TR172001 Solicitation number
- CRO Support for NCATS Drug Substance Development and Manufacture Award Notice · Posted Mar 1, 2016
- Contract value 100% obligated
- $131,421.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Kansas City, MO 64110, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,543 | |
| Supplemental Agreement for work within scope | $14,738 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $122,226 |
About this award
This task order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The task order, valued at $131,421.00, is for analytical method development and validation, characterization, and stability studies of the drug substance ML-246 under the parent contract "CRO Support for NCATS Drug Substance Development and Manufacture." The contract does not have a small business set-aside designation. Mriglobal, as the prime contractor, has extensive experience providing a wide range of scientific research, testing, training, and product development services to federal agencies, including the Department of Health and Human Services (HHS) and the Department of Defense (DOD).
Quick answers
Who was awarded contract HHSN27100001?
HHSN27100001 was awarded to Mriglobal by National Institute on Drug Abuse (National Institutes of Health) on August 7, 2017.
How much is contract HHSN27100001 worth?
The government has obligated $131,421 on HHSN27100001.
Which agency awarded contract HHSN27100001?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN27100001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract HHSN27100001 an order under another contract?
Yes. HHSN27100001 is a delivery order under HHSN271201700006I, an indefinite delivery contract, on CRO Support for NCATS Drug Substance Development and Manufacture.
Was contract HHSN27100001 competed?
The extent of competition for HHSN27100001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award